The novel class of GLP-1 receptor agonist and GIP co-agonist medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, provide promising improvements in metabolic control. https://ghk-cu-copper-peptide909675.jiliblog.com/100106475/tirzepatide-a-comparative-examination